文献速递眼底病与葡萄膜炎

培养阳性内源性眼内炎的病原体特异性临床特征与结局:12年多中心队列研究

Organism-Specific Clinical Features and Outcomes of Culture-Positive Endogenous Endophthalmitis: A Multicenter Cohort Study Over 12 Years.
PubMed 文献 · Am J Ophthalmol · 2026-09-26

该多中心回顾性队列研究纳入2012至2024年间9家学术三级转诊中心收治的305眼培养阳性内源性眼内炎,按病原体分层分析临床表现、治疗与结局。结果表明不同病原体组在感染来源、视力预后及眼球丢失风险上存在显著差异,革兰阴性菌尤其沙雷菌摘除眼球风险最高,就诊时视力是最终视力的最主要预后因素。

要点

  • 真菌性眼内炎免疫抑制和静脉吸毒比例更高,革兰阴性菌更常见泌尿系来源。
  • 革兰阴性菌眼球摘除率27.7%,其中沙雷菌高达85.7%。
  • 就诊时视力是各病原体组最终视力最一致的预后预测因素。

核心结论

  • 不同病原体组的内源性眼内炎在临床表现、感染来源、管理和结局上存在差异。
  • 玻璃体培养阳性率低且与血培养病原体一致性不完美,给病原体导向治疗带来困难。
  • 就诊时视力是最终视力的最主要预后因素,但革兰阴性菌感染尤其沙雷菌显著增加眼球丢失风险。

研究设计与样本

  • 回顾性多中心临床队列研究,纳入2012至2024年9家学术三级转诊中心培养阳性内源性眼内炎患眼。
  • 共纳入305眼(261例患者),按病原体分层:金黄色葡萄球菌115眼(37.7%)、链球菌41眼(13.4%)、其他革兰阳性菌29眼(9.5%)、革兰阴性菌47眼(15.4%)、真菌59眼(19.3%)、混合感染14眼(4.6%)。
  • 采用多变量混合效应模型确定最终视力的预测因素。

主要发现

  • 血培养阳性202/305眼(66.2%),玻璃体培养阳性95眼(31.1%),房水培养阳性27眼(8.9%);配对血和眼培养病原体一致24/39例(62%)。
  • 真菌组免疫抑制和静脉吸毒比例更高(P < .05),革兰阴性菌组泌尿系来源更常见(P < .001)。
  • 多数细菌组就诊时平均logMAR为1.78-2.14,真菌组为1.30(P < .001);最终平均logMAR细菌组为1.31-1.75,真菌组为1.13(P = .06)。
  • 视网膜脱离在金黄色葡萄球菌和链球菌感染中最常见;眼球摘除率在革兰阴性菌最高(27.7%),其中沙雷菌达85.7%(P = .05)。
  • 校正混合效应模型中,就诊时视力较差是各病原体组最终视力较差的最一致预测因素;在金黄色葡萄球菌和链球菌感染中,全身感染来源、培养阳性和需行PPV是最终视力的预测因素。

临床怎么用

  • 内源性眼内炎应结合病原体类型评估预后,革兰阴性菌尤其沙雷菌感染需警惕眼球丢失高风险。
  • 就诊时视力是主要预后指标,可用于临床决策和患者沟通。
  • 玻璃体培养阳性率低且与血培养一致性有限,病原体导向治疗需谨慎解读培养结果。

局限性

  • 回顾性研究设计可能引入选择偏倚和信息偏倚。
  • 仅纳入培养阳性病例,可能低估培养阴性内源性眼内炎的真实负担。
  • 多中心数据虽增加样本量,但各中心诊疗方案差异可能影响结局比较。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Evaluate differences in presentation, management, and outcomes of culture-positive endogenous endophthalmitis by microbial pathogen. DESIGN: Retrospective multicenter clinical cohort study PARTICIPANTS: Eyes with a clinical diagnosis of endogenous endophthalmitis that underwent anterior chamber paracentesis, intravitreal aspiration, or pars plana vitrectomy (PPV) and intravitreal injection of antimicrobials with no recent exogenous risk factors. METHODS: Clinical presentation, culture characteristics, treatment and outcomes for culture-positive endogenous endophthalmitis from 2012 to 2024 at 9 academic tertiary referral centers stratified by microbial pathogen were reported. Multivariable mixed-effects models were used to determine predictors of final visual acuity (VA). MAIN OUTCOMES AND MEASURES: Final VA, retinal detachment, enucleation. RESULTS: About 305 eyes from 261 patients were included: Staphylococcus aureus 115 (37.7%), Streptococcus 41 (13.4%), other gram-positive 29 (9.5%), gram-negative 47 (15.4%), fungal 59 (19.3%), and polymicrobial 14 (4.6%) infections. Blood cultures were positive in 202/305 eyes (66.2%), vitreous in 95 (31.1%), and aqueous in 27 (8.9%); concordant organism growth in paired blood and eye cultures occurred in 24/39 cases (62%). Fungal cases had higher rates of immunosuppression and intravenous drug use (P < .05), while gram-negative cases more often had urinary sources (P < .001). Presenting and final VA varied across groups (presenting mean logMAR 1.78-2.14 for most bacteria vs 1.30 for fungal, P < .001; final mean logMAR 1.31-1.75 for bacteria vs 1.13 for fungal, P = .06). Retinal detachment was most frequent with S. aureus and Streptococcus. Enucleation was highest with gram-negative organisms (27.7%), driven by Serratia (85.7%, P = .05). In adjusted mixed-effects models, worse presenting VA was the most consistent predictor of poorer final VA across groups; in S. aureus and Streptococcus infections, systemic infection source, culture positivity, and need for PPV were predictors of final VA. CONCLUSIONS: In this multicenter cohort, organism groups were associated with distinct presentations, sources, management, and outcomes. Low intraocular culture yield and imperfect concordance with blood cultures complicate pathogen-directed therapy. Presenting VA is the dominant prognostic factor, but gram-negative infections-particularly Serratia-carry markedly higher risk of globe loss. These findings support organism-informed clinical decision-making and highlight the need for improved intraocular diagnostics and targeted interventions.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Ciociola Kelly E, Calderon R, Weng P, et al. Organism-Specific Clinical Features and Outcomes of Culture-Positive Endogenous Endophthalmitis: A Multicenter Cohort Study Over 12 Years. Am J Ophthalmol. 2026. PMID: 42800654. doi:10.1016/j.ajo.2026.09.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。